Axsome Therapeutics, Inc. 4

Axsome Therapeutics COO Mark L. Jacobson exercised 10,000 stock options at $12.95 and sold the 10,000 resulting common shares at a weighted average of $208.65 on 2026-09-03, leaving him with 104,954 shares owned.

On 2026-09-03, Mark L. Jacobson, Chief Operating Officer of Axsome Therapeutics, Inc., exercised 10,000 stock options at an exercise price of $12.95 per share, acquiring 10,000 shares of common stock, and immediately sold all 10,000 underlying shares in the open market at a weighted average price of $208.65 per share pursuant to a pre-approved Rule 10b5-1 trading plan. The option exercise, originally granted on 2020-03-19 and set to expire on 2029-03-19, generated an approximate spread of about $1.96 million before taxes and commissions, effectively monetizing the award without increasing his net share ownership, which remained at 104,954 shares after the transactions. The filing notes that the sale price reflects a weighted average over multiple trades within a price range of $206.41 to $210.34, and the option exercise was characterized as a routine exercise of long-held equity awards prior to their expiration.

Filing Facts

CIK

1579428

Ticker

AXSM

Form

4

Source Type

fda

Accession

0001193125-26-382277

Alert Tier

6